EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Female Mice with HSD17B1 Inactivation Show Mild Hyperandrogenism without Notable Impact on Reproductive Function or Bone

Arttu Junnila iD, Nataliia Petruk, Hanna Heikelä, Pekka Postila, Janne Hakkarainen, Guillermo Martinez-Nieto, Esperanza Uceda-Rodriguez, Francisco Ruiz-Pino, Manuel Tena-Sempere iD, Claes Ohlsson iD, Petra Sipilä, Terhi J Heino und 2 weitere

Endocrinology · 2025

DOI: 10.1210/endocr/bqaf167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2025. Verfasst von Arttu Junnila und 13 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku FI-20520, Finland. Hauptthemen laut MEDLINE: Reproduction, Hyperandrogenism, Estradiol Dehydrogenases, Bone and Bones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Turku, Research Council of Finland's Flagship InFLAMES, Sigrid Juselius Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

17β-hydroxysteroid dehydrogenase 1 (HSD17B1) is the primary enzyme responsible for the activation of estrone (E1) to estradiol (E2) in ovaries and extra-gonadal tissues of both humans and rodents. In the present study, molecular modeling identified the substitution of His222 in the human HSD17B1 enzyme with glycine in the mouse as the key determinant for the different steroid specificity between the species. Furthermore, Ser143Ala mutation at the active site of mouse HSD17B1 resulted in a total loss of E1 to E2 conversion by HSD17B1. This resulted in elevated intraovarian and circulating E1 concentrations in adult HSD17B1 Ser143Ala knock-in (HSD17B1-KI) females, but no changes in E2 concentrations were observed compared to the wild-type mice. Androstenedione and dihydrotestosterone were also elevated in the HSD17B1-KI ovaries, associated with elevated circulating LH. However, the effect of HSD17B1 inactivation on female reproductive development and function was mild, primarily resulting in a slight decrease in ovarian weight in older HSD17B1-KI mice, without notable effects on fertility. Expression of genes related to steroid biosynthesis, mitochondrial metabolism, and known markers of polycystic ovary syndrome was found to be upregulated in adult HSD17B1-KI ovaries. However, no alterations in the structure or function of extra-gonadal tissues were observed, and the uterus and bone phenotypes in the HSD17B1-KI females were unaffected. Our results demonstrate that the blockade of HSD17B1-dependent E2 synthesis is successfully compensated for in mouse in vivo, resulting in only a mild ovarian estrogen and androgen imbalance but no significant adverse effects on reproductive or bone health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ReproductionHyperandrogenismEstradiol DehydrogenasesBone and BonesAnimalsFemaleMiceOvaryEstradiolHumansEstrone17-Hydroxysteroid Dehydrogenases

Stichwörter der Autor:innen

HSD17B1bone healthestrogensfemale reproductionhyperandrogenismsteroidogenesis

Substanzen

Estradiol DehydrogenasesEstradiolhydroxysteroid (17-beta) dehydrogenase 1, mouseEstrone17-Hydroxysteroid Dehydrogenases

Autor:innen und Institutionen

  • Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku FI-20520, Finland.
  • Organon R&D Finland, Turku FI-20520, Finland.
  • Turku Center for Disease Modeling, University of Turku, Turku FI-20520, Finland.
  • Department of Cell Biology, Physiology and Immunology, University of Cordoba, and Instituto Maimónides de Investigación Biomédica de Córdoba, 14071 Córdoba, Spain.
  • The Sahlgrenska Osteoporosis Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 41345 Gothenburg, Sweden.

ORCID-Profile: Arttu Junnila, Manuel Tena-Sempere, Claes Ohlsson, Matti Poutanen

Förderung

  • University of Turku
  • Research Council of Finland's Flagship InFLAMES
  • Sigrid Juselius Foundation
  • Organon R&D Finland Ltd
  • Research Council of Finland’s Flagship InFLAMES

Zitieren

APA

Junnila, A., Petruk, N., Heikelä, H., Postila, P., Hakkarainen, J., Martinez-Nieto, G., Uceda-Rodriguez, E., Ruiz-Pino, F., Tena-Sempere, M., Ohlsson, C., Sipilä, P., Heino, T. J., Määttä, J., & Poutanen, M. (2025). Female Mice with HSD17B1 Inactivation Show Mild Hyperandrogenism without Notable Impact on Reproductive Function or Bone. Endocrinology. https://doi.org/10.1210/endocr/bqaf167

Vancouver

Junnila A, Petruk N, Heikelä H, Postila P, Hakkarainen J, Martinez-Nieto G, et al. Female Mice with HSD17B1 Inactivation Show Mild Hyperandrogenism without Notable Impact on Reproductive Function or Bone. Endocrinology. 2025. doi:10.1210/endocr/bqaf167

BibTeX
@article{Junnila2025,
  author = {Junnila, Arttu and Petruk, Nataliia and Heikelä, Hanna and Postila, Pekka and Hakkarainen, Janne and Martinez-Nieto, Guillermo and Uceda-Rodriguez, Esperanza and Ruiz-Pino, Francisco and Tena-Sempere, Manuel and Ohlsson, Claes and Sipilä, Petra and Heino, Terhi J and Määttä, Jorma and Poutanen, Matti},
  title = {Female Mice with HSD17B1 Inactivation Show Mild Hyperandrogenism without Notable Impact on Reproductive Function or Bone},
  journal = {Endocrinology},
  year = {2025},
  doi = {10.1210/endocr/bqaf167}
}
Kostenlos starten →